(lp0
S'ORAMED PHARMACEUTICALS INC.  Files An 8-K Other Events Market Exclusive - Mar 21, 2017 Oramed Pharmaceuticals Inc.  is engaged in the field of oral delivery solutions for drugs and vaccines presently delivered via injection.Oramed Pharma  Appoints Dr. Ronald Law as CSO - StreetInsider.comOramed Appoints Dr. Ronald Law as Chief Strategy Officer - Yahoo Finance'
p1
aS'5.96 MarketWatch - Apr 21, 2011 Oramed Pharmaceuticals Inc. Watchlist CreateORMPAlert. Closed. Last Updated: Mar 20, 2017 3:55 p.m.. $ 5.96. -0.07 -1.16%.'
p2
aS'Oramed: The Atypical Biotechnology Company With Great Upside Potential Seeking Alpha - Jul 1, 2016 Oramed , the biotech company involved in the research and development of orally deliverable insulin, is a great investment opportunity for investors that are looking for a growing small stock in the biotechnology industry.'
p3
aS'Oramed Pharmaceuticals Inc. ORMP  Wall Street Journal - Feb 11, 2013 Oramed Pharmaceuticals Inc. ORMP . search. View All companies. AT CLOSE 3:38 PM EST 03/10/17. $6.03 USD; 0.01 0.17%.'
p4
aS'Does Oramed Pharmaceuticals Pass The Smell Test? Seeking Alpha - May 23, 2014 First off, thank you to the M.D. and Pharma classmates who helped to explain the intricacies of the clinical trial and drug patent process.'
p5
aS'Rating &amp; PT Roundup on Oramed Pharmaceuticals Inc.  FedEx ... Sherwood Daily - 15 hours ago Sell-side analysts are offering a consensus Buy rating on shares of Oramed Pharmaceuticals Inc. . Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation&nbsp;...'
p6
aS"Oramed Pharmaceuticals'  CEO Nadav Kidron Hosts Phase IIb Clinical ... Seeking Alpha - Jul 29, 2016 I encourage you to review the cautionary language about forward-looking statements in today's press release, which can be found on Oramed's website, as well as the Company's filings with the Securities and Exchange Commission including, without&nbsp;..."
p7
aS"One company that is attempting to do exactly that right now, and that looks to ... Seeking Alpha - Feb 17, 2017 One company that is attempting to do exactly that right now, and that looks to have an attractive pitch, is Oramed Pharmaceuticals Inc. . The company's CEO, Nadav Kidron, featured on CNBC's Squawk Box earlier this week and highlighted&nbsp;..."
p8
aS"Weekly Biotech Report Part II, Oramed Pharmaceuticals, Inc.  Market Exclusive - May 23, 2016 In the forward looking element of last week's Market Exclusive biotechnology weekly report, we discussed two companies that were set to report key data during the then week ahead.Early Trials Show an Insulin Pill Can Lower Diabetics' Blood Sugar Levels - ScienceAlert"
p9
aS"Stock Perspective: Oramed Pharmaceuticals Inc.  Earnings in View Aiken Advocate - Mar 22, 2017 Investors and analysts will be looking ahead to Oramed Pharmaceuticals Inc. 's next earnings report which is slated to be released sometime on or around 2017-04-05 for the period ending on 2017-02-28."
p10
a.